Long-term study links moderate coffee and tea consumption to 18% lower dementia risk
By
Bender
Right out the toaster. Reliable, with some real depth.
Summary
A long-term study tracking over 130,000 people for four decades found that regular consumption of moderate amounts of caffeinated coffee or tea is associated with an 18% lower risk of developing dementia compared to rare consumption. The research also indicates that caffeine consumers performed better on cognitive tests and showed better brain health outcomes.
Key quotes
· 4 pulledResearchers from Mass General Brigham tracked more than 130,000 people for over four decades and found that those who regularly consumed moderate amounts of caffeinated coffee or tea had an 18 percent lower risk of developing dementia compared to those who rarely touched the stuff.
A decades-long study suggests that your daily caffeine fix might be doing more than jolting you through morning meetings – it could also be quietly helping your brain hold it together.
Caffeine swiggers also scored better on some cognitive tests and were less
Decades of data suggest people who stick to a couple of brews fare better in terms of gray matter
You might also wanna read
Creatine supplement shows cognitive benefits: slows early Alzheimer's decline by 30% and improves mental performance, studies find
A comprehensive review (2025) and clinical trial (2026) reveal that creatine, widely used as a muscle-building supplement, also crosses the
thesciverse.org·10h ago
Japanese researchers develop vitamin K-like compounds that may help convert brain cells into neurons
Japanese researchers have developed a new family of vitamin K-like molecules that may help immature brain cells transition into neurons. Whi
zmescience.com·1d ago
Gladstone Scientists Develop New Tool to Map Brain Waste Clearance Mechanisms
Gladstone scientists have developed a new tool to trace how the brain clears waste, revealing surprising new biology about the brain's self-
gladstone.org·2d ago
Karolinska Institutet study finds SSRIs affect developing nerve cell metabolism differently
A new study from Karolinska Institutet reveals that different SSRI medications affect metabolic processes in developing nerve cells in disti
news.ki.se·3d ago
Nutrigenomics framework identifies vitamin B3 as potential therapy for NAXD deficiency disorder
This article presents a nutrigenomics framework that systematically identifies monogenic diseases that can be treated with vitamin supplemen
Large longitudinal study examines delayed cortical thinning as biomarker for attention problems, highlighting sex differences in youth
This study examines whether delayed age-related cortical thinning is a reliable biomarker for attention problems and ADHD in youth. Using a
pnas.org·4d ago